BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 30575915)

  • 1. Increased long noncoding RNA LINP1 expression and its prognostic significance in human breast cancer.
    Liu XM; Yang B; Han J
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8749-8754. PubMed ID: 30575915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long non-coding RNA expression profiles predict metastasis in lymph node-negative breast cancer independently of traditional prognostic markers.
    Sørensen KP; Thomassen M; Tan Q; Bak M; Cold S; Burton M; Larsen MJ; Kruse TA
    Breast Cancer Res; 2015 Apr; 17(1):55. PubMed ID: 25887545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-Noncoding-RNA HOTAIR Upregulation is Associated with Poor Breast Cancer Outcome: A Systematic Review and Meta Analysis.
    Suwardjo S; Gilang Permana K; Aryandono T; Heriyanto DS; Anwar SL
    Asian Pac J Cancer Prev; 2024 Apr; 25(4):1169-1182. PubMed ID: 38679975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic and clinicopathological role of long non-coding RNA taurine upregulated 1 in various human malignancies: A systemic review and meta-analysis.
    Wang X; Chen X; Zhang D; Yang G; Yang Z; Yin Z; Zhao S
    Tumour Biol; 2017 Jul; 39(7):1010428317714361. PubMed ID: 28671045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of prostate tumor overexpressed 1 correlates with tumor progression and predicts poor prognosis in breast cancer.
    Lei F; Zhang L; Li X; Lin X; Wu S; Li F; Liu J
    BMC Cancer; 2014 Jun; 14():457. PubMed ID: 24947166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA LINC01116 competes with miR-145 for the regulation of ESR1 expression in breast cancer.
    Hu HB; Chen Q; Ding SQ
    Eur Rev Med Pharmacol Sci; 2018 Apr; 22(7):1987-1993. PubMed ID: 29687853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NEAT expression is associated with tumor recurrence and unfavorable prognosis in colorectal cancer.
    Li Y; Li Y; Chen W; He F; Tan Z; Zheng J; Wang W; Zhao Q; Li J
    Oncotarget; 2015 Sep; 6(29):27641-50. PubMed ID: 26314847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High RRM2 expression has poor prognosis in specific types of breast cancer.
    Shi SC; Zhang Y; Wang T
    PLoS One; 2022; 17(3):e0265195. PubMed ID: 35290409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic implications of lncRNA NORAD in breast cancer.
    Zhang Y; Fan X; Hong J; Yang E; Xuan C; Fang H; Ding X
    Sci Rep; 2023 Nov; 13(1):20426. PubMed ID: 37993524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between LINC00341 expression and cancer prognosis.
    Liao M; Li B; Zhang S; Liu Q; Liao W; Xie W; Zhang Y
    Oncotarget; 2017 Feb; 8(9):15283-15293. PubMed ID: 28146429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of
    Huang Y; Jian W; Zhao J; Wang G
    Onco Targets Ther; 2018; 11():2177-2184. PubMed ID: 29713186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathological features and prognostic value of CD276 expression in breast cancer: A meta-analysis.
    Su H; Lin X; Huo J; Zhang F
    Asian J Surg; 2023 Nov; 46(11):5323-5329. PubMed ID: 37543458
    [No Abstract]   [Full Text] [Related]  

  • 13. Long noncoding RNA LINP1: scaffolding non-homologous end joining.
    Sakthianandeswaren A; Liu S; Sieber OM
    Cell Death Discov; 2016; 2():16059. PubMed ID: 27551547
    [No Abstract]   [Full Text] [Related]  

  • 14. Diagnostic, clinicopathological features and prognostic value of B7x expression in Chinese women with breast cancer: A meta-analysis.
    Su H; Lin X; Huo J; Zhang F
    Asian J Surg; 2023 Nov; 46(11):5210-5216. PubMed ID: 37481357
    [No Abstract]   [Full Text] [Related]  

  • 15. Interpreting quantitative RNA expression prognostic and predictive results generated from synchronous rather than solitary breast cancers.
    Sorscher S; Gor P
    Biomarkers; 2024 May; 29(3):115-117. PubMed ID: 38444305
    [No Abstract]   [Full Text] [Related]  

  • 16. Coding roles of long non-coding RNAs in breast cancer: Emerging molecular diagnostic biomarkers and potential therapeutic targets with special reference to chemotherapy resistance.
    Kashyap D; Sharma R; Goel N; Buttar HS; Garg VK; Pal D; Rajab K; Shaikh A
    Front Genet; 2022; 13():993687. PubMed ID: 36685962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Research updates on the clinical implication of long noncoding RNA in digestive system cancers and chemoresistance.
    Miao X; Wang F; Wang T; Razak SRA; Yunus MA; Ismail IS
    3 Biotech; 2021 Sep; 11(9):423. PubMed ID: 34603923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long Noncoding RNAs Regulate the Radioresistance of Breast Cancer.
    Li Z; Wang F; Zhu Y; Guo T; Lin M
    Anal Cell Pathol (Amst); 2021; 2021():9005073. PubMed ID: 34595090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. lncRNA and breast cancer: Progress from identifying mechanisms to challenges and opportunities of clinical treatment.
    Jin H; Du W; Huang W; Yan J; Tang Q; Chen Y; Zou Z
    Mol Ther Nucleic Acids; 2021 Sep; 25():613-637. PubMed ID: 34589282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticancer effects of melatonin via regulating lncRNA JPX-Wnt/β-catenin signalling pathway in human osteosarcoma cells.
    Li Y; Zou J; Li B; Du J
    J Cell Mol Med; 2021 Oct; 25(20):9543-9556. PubMed ID: 34547170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.